Tumor cell capture from blood by flowing across antibody-coated surfaces

The load of circulating tumor cells (CTC) is related to poor outcomes in cancer patients. A sufficient number of these cells would enable a full characterization of the cancer. An approach to probe larger blood volumes, allowing for the detection of more of these very rare CTC, is the use of leukaph...

Full description

Saved in:

Bibliographic Details
Published in:	Lab on a chip Vol. 19; no. 6; p. 1006
Main Authors:	Andree, K C, Mentink, A, Nguyen, A T, Goldsteen, P, van Dalum, G, Broekmaat, J J, van Rijn, C J M, Terstappen, L W M M
Format:	Journal Article
Language:	English
Published:	England 13-03-2019
Subjects:	Antibodies, Immobilized - chemistry Antibodies, Immobilized - immunology Cell Line, Tumor Epithelial Cell Adhesion Molecule - immunology Glass - chemistry Humans Lab-On-A-Chip Devices Neoplastic Cells, Circulating - metabolism Surface Properties Time-Lapse Imaging
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The load of circulating tumor cells (CTC) is related to poor outcomes in cancer patients. A sufficient number of these cells would enable a full characterization of the cancer. An approach to probe larger blood volumes, allowing for the detection of more of these very rare CTC, is the use of leukapheresis. Currently available techniques allow only the analysis of a small portion of leukapheresis products. Here, we present a method that uses flow rather than static conditions which allows processing of larger volumes. We evaluated the conditions needed to isolate tumor cells from blood while passing antibody coated surfaces. Results show that our set-up efficiently captures cancer cells from whole blood. Results show that the optimal velocity at which cells are captured from blood is 0.6 mm s-1. Also, it can be concluded that the VU1D9 antibody targeting the EpCAM antigen has very high capture efficiency. When using an antibody that does not capture 100% of all cells, combining multiple antibodies on the capture surface is very beneficial leading to an increase in cell capture and is therefore worthwhile considering in any cancer cell capture methodology.
ISSN:	1473-0189
DOI:	10.1039/C8LC01158C